Ignite Creation Date:
2024-05-06 @ 8:29 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06394674
Status:
RECRUITING
Last Update Posted:
2024-05-07
First Post:
2024-04-27
Brief Title:
High-dose Furmonertinib in the Treatment in Patients With Advanced Metastatic NSCLC With Progressed After First- or Second-line Treatment With Osimertinib
Sponsor:
Changhai Hospital
Organization:
Changhai Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-Small Cell Lung Cancer |
Keywords:
| Name | View |
|---|---|
| furmonertinib | View |